Abstract Aims/hypothesis: One-third of normoalbuminuric type 1 diabetic patients show immunoreactive nephrin in urine. Offspring of type 2 diabetic patients are insulinresistant and susceptible to the development of diabetes. We investigated whether the offspring of type 2 diabetic patients show nephrin in urine and whether possible nephrinuria is associated with insulin resistance. Methods: : Urinary proteins from timed overnight urine collections from 128 offspring of type 2 diabetic patients and 9 control subjects were analysed by western blotting using an antibody against nephrin. Glucose metabolism was assessed by OGTT and IVGTT and the euglycaemic-hyperinsulinaemic clamp technique. Results: Of the offspring, 12.5% were strongly and 14.1% weakly positive for a 100-kDa urinary protein. All controls were negative. During the first 10 min of an IVGTT, the offspring strongly positive for the urinary protein had a higher inysulin response than the offspring without the protein (3,700 vs 2,306 pmol l −1 min −1 , p=0.007). Insulin sensitivity (the rate of wholebody glucose uptake divided by the steady-state insulin level×100) was lower among the offspring strongly positive for the urinary protein than among the offspring negative for the protein (11.3 vs 15.8 μmol kg −1 min
Introduction
Type 2 diabetes is a heterogeneous metabolic disorder characterised by defects in insulin secretion or in insulin sensitivity [1] . Diabetes causes a variety of end-organ complications, including retinopathy, neuropathy, atherosclerosis and nephropathy. Type 2 diabetes can be present subclinically for many years [2] , and a proportion of type 2 diabetic patients already have microalbuminuria at the time of diagnosis [3] . Kidney biopsies have shown that glomerular changes are more heterogeneous and that albuminuria may be a less specific marker for diabetic nephropathy in type 2 diabetes than in type 1 diabetes [4, 5] . Microalbuminuria has been associated with insulin resistance in patients with type 2 diabetes and is considered to be a component of the metabolic syndrome [6, 7] .
The kidney's glomerular filtration barrier is formed of capillary endothelium, glomerular basement membrane and podocytes, which are located on the outer surface of the filtration barrier [8] . The podocytes form primary and secondary foot processes, which interdigitate to form a microscopic filtration structure, the slit diaphragm. A key component of the slit is a transmembrane protein, nephrin [9] . Two major mutations in the nephrin gene lead to a massively proteinuric disease, congenital nephrotic syndrome of the Finnish type [10] . In addition to podocytes, pancreatic beta cells express nephrin but its function in the pancreas is not yet known [11] . Interestingly, experimental models of diabetes and human studies show alterations in glomerular nephrin mRNA and protein levels [12] [13] [14] . Other podocyte-specific proteins may also show expression changes in human proteinuric diseases [15] .
In our previous study, one-third of type 1 diabetic patients, including normoalbuminuric patients, showed immunoreactive nephrin in urine [16] . Furthermore, podocyturia [17] and changes in podocyte structure and density in the early stages of diabetic nephropathy in type 2 diabetes [18] have been reported. These results suggest specific, early damage of podocytes and, particularly, of the slit diaphragm as a consequence of diabetes. Type 2 diabetic patients may already have microalbuminuria at the time of diagnosis, as may healthy subjects with impaired glucose tolerance [19] and insulin resistance [20] . We investigated whether the offspring of type 2 diabetic patients, who are prone to diabetes, exhibit podocyte protein nephrin in urine in association with insulin resistance.
Subjects, materials and methods
Subjects A total of 128 healthy offspring of type 2 diabetic patients and 9 control subjects were included in the study. The control subjects had a negative family history of diabetes. The diabetic patients (probands) were randomly selected among type 2 diabetic patients living in the region of the Kuopio University Hospital. Spouses of the probands had to have normal glucose tolerance in an OGTT. One to three offspring from each family were included in metabolic studies. All study subjects gave a written informed consent and the study was approved by the Ethics Committee of the University of Kuopio.
Study design On the first day, blood pressure was measured in a sitting position with a mercury sphygmomanometer after a 5 min rest, using the average of three measurements. Blood samples were drawn after 12 h fasting followed by an OGTT (75 g glucose). Glucose and insulin samples were drawn at −10, 0, 30, 60 and 120 min. On the second day an IVGTT was performed to determine the first-phase insulin secretion capacity after 12 h of fasting. After baseline blood collection, a bolus of glucose (300 mg/kg in a 50% solution) was given within 30 s into the antecubital vein. Blood glucose and plasma insulin samples (arterialised venous blood) were drawn at −5, 0, 2, 4, 6, 8, 10, 20, 30, 40, 50 and 60 min. After an IVGTT, insulin sensitivity was evaluated with the euglycaemichyperinsulinaemic clamp technique using an insulin infusion rate of 240 pmol min −1 (m 2 ) −1 body surface area. Blood glucose for the next 120 min was clamped at 5.0 mmol/l by infusing 20% glucose at varying rates according to blood glucose measurements performed at 5-min intervals. Mean CV was below 4% during the last hour of the clamp in all study groups. Indirect calorimetry before the clamp and during the last 20 min of the clamp was performed using a computerised flow-through canopy gas analyser system (Deltatrac; TM Datex, Helsinki, Finland), as previously described [21] . Mean values of the data during the last 20 min of the clamp were used to calculate the M-value (whole body glucose uptake, WBGU; glucose infusion μmol kg lean body mass
), glucose oxidation and lipid oxidation. The rates of non-oxidative glucose disposal during the clamp were estimated by subtracting the rate of glucose oxidation from the glucose infusion rate. Because insulin levels during the clamp were significantly higher in offspring with a strong urinary 100-kDa protein band than in offspring with a weak protein band or without a band, insulin sensitivity was expressed as the ratio of glucose infusion to prevailing plasma insulin level (M/I×100). Similarly, oxidative and non-oxidative glucose disposal rates were normalised to insulin concentration during the clamp. The serum lipids and lipoproteins were measured as previously described [21] .
Sample preparation Timed overnight urine was collected before the clamp and preserved at −20°C until analysed. Urinary albumin concentration was measured by kinetic nephelometry (Immage Immunochemistry Systems Microalbumin Reagent; Beckman Coulter, CA, USA). Total urinary protein concentration was measured in 42 subjects with a colorimetric RC CD Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA) using the microfuge tube assay protocol according to the manufacturer's instructions. The relative proportion of albumin from total urinary protein was 0.04±0.013 (mean±SD) in study subjects and corresponded well to values reported in our previous study concerning type 1 diabetic patients [16] . Therefore, we were able to calculate the concentration of total urinary proteins using the albumin concentration for the rest of the samples and the samples were prepared as previously described [16] . In brief, sample volumes corresponding to 30 μg of total protein were precipitated with 10% (w/v) trichloroacetic acid in PBS on ice for 30 min and then centrifuged for 10 min at 13,100 g at +4°C, and the pellets were washed twice with ice-cold acetone. The samples were air-dried and dissolved in Laemmli buffer (62.5 mmol/l Tris-HCl (pH 6.8), 10% (v/v) glycerol, 2% (w/v) SDS, 5% (w/v) 2-mercaptoethanol and 0.05% (w/v) bromophenol blue) followed by heating at +95°C for 5 min. Positive control (nephrinuric type 1 diabetic urine) samples were prepared similarly. Normal kidney tissue was obtained from cadaver kidneys taken for transplantation but not grafted because of vascular anatomical abnormalities (Department of Surgery, Helsinki University Central Hospital, Finland) in accordance with the principles of the Declaration of Helsinki. Glomeruli were isolated as described earlier [22] , followed by extraction of membrane proteins using RIPA buffer (150 mmol/l NaCl, 1% v/v NP-40, 0.5% w/v Na-deoxycholate, 0.1% w/v SDS and 50 mmol/l Tris, pH 8.0) with Complete Miniprotease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany).
SDS-PAGE and western blotting
The samples were run through reducing 10% polyacrylamide gels in the Protean Mini-gel electrophoresis system using Ready Gels (Bio-Rad Laboratories). A urine sample from a type 1 diabetic patient, showing protein bands of 75, 40 and 32 kDa, was used as a positive control in every gel. After the run the proteins were transferred onto nitrocellulose filters (Amersham Biosciences, Little Chalfont, UK) followed by blocking of the filter for 2 h at room temperature with 3% (w/v) non-fat dried milk (Valio, Helsinki, Finland) in PBS. The filters were incubated with antibody Aff338 (1:5) in PBS containing 1% (w/v) non-fat dried milk and 0.02% (w/v) sodium azide for 1.5 h at room temperature, and then washed several times in PBS containing 0.2% (v/v) Tween 20, followed by incubation with peroxidase-conjugated affinity-purified goat anti-rabbit IgG antibody (Jackson ImmunoResearch Laboratories, West Grove, PA, USA; 1:40 000) for 1 h at room temperature, and washed as above. The bound antibody was detected with Super Signal ECL substrate (Pierce, Rockford, IL, USA). The Aff338 rabbit polyclonal antibody was raised against recombinant fusion protein α-435 mimicking the major splicing variant designated as nephrin α [16] . The western blot analyses were carried out and interpreted by an experienced immunologist blinded to both the results of the metabolic studies and the grouping of the study subjects.
Statistical analysis Data were analysed with SPSS for Windows (SPSS, Chicago, IL, USA) and expressed as means±SEM unless otherwise stated. Because of skewed distribution, insulin and total triglycerides were logarithmically transformed before statistical analyses. The differences over three or more groups were estimated by ANOVA for independent samples. A p value of <0.05 was considered statistically significant. If the difference was statistically significant, comparisons of the two groups were performed using the unpaired t-test. Regression analysis was performed to evaluate the association of different variables with M/I.
Results
Of all offspring, 26.6% had a 100-kDa urinary protein visible with a nephrin antibody. Nephrin antibody also showed a protein of similar size in the glomerular lysate (Fig. 1b, lane 2) . These subjects were divided into strongly positive (SPOS) (12.5%) and weakly positive (WPOS) (14.1%) groups for statistical analyses (Fig. 1) . All control subjects were negative regarding the 100-kDa protein. Table 1 presents the clinical characteristics of the study subjects grouped by the presence of the 100-kDa protein.
Control subjects had a higher serum HDL cholesterol level than the offspring, but otherwise the groups did not differ.
During the first 10 min of the IVGTT the insulin AUC differed between the groups (ANOVA, p=0.029) (Fig. 2) . The SPOS group had higher insulin AUC than the offspring without the 100-kDa protein (the NEG group) (3,700±706 vs 2,306±159 pmol·l ; p=0.007) (Fig. 3) . The M/I of the WPOS group fell between the values in these groups (14.1±1.6 μmol·kg ; p=NS). The results were essentially similar when subjects with IGT and IFG were excluded from statistical analyses (p=0.006 among the three groups). The difference in M/I between the groups disappeared after adjustment for the insulin AUC during the first 10 min of IVGTT (ANCOVA), suggesting that subjects who were positive for the 100-kDa urinary protein were fully capable of compensating their insulin resistance by increased insulin secretion.
Non-oxidative glucose disposal also differed between the groups (ANOVA, p=0.023); it was lower in the SPOS group than in the NEG group (6.4±0.9 vs 10±0.5 μmol· kg
·l −1 ; p=0.007) but did not differ significantly from that of the WPOS group (9±1.3 μmol·kg (Fig. 3) . The groups did not differ with respect to the rates of oxidative glucose disposal (4.7±0.5, 5.6±0.5 and 5.6±0.2 μmol·kg −1 ·min
, respectively; p=NS). Fasting glucose oxidation, lipid oxidation and free fatty acid levels were similar between the groups (data not shown).
In multiple linear regression analysis the 100-kDa urinary protein was significantly associated with the rates of WBGU and non-oxidative glucose disposal independently of several factors that are known to associate with insulin resistance (Table 2) . Altogether, 79% of offspring and 78% of control subjects showed a urinary protein band of 185-200 kDa (Fig. 1) . Subjects positive or negative for this band did not differ with respect to the clinical characteristics and laboratory parameters listed in Table 1 . Similarly, first-phase insulin secretion and insulin sensitivity did not differ between these subjects (data not shown).
Discussion
This is the first study demonstrating the association of the presence of urinary podocyte protein with insulin resistance in subjects susceptible to the development of type 2 diabetes. Our study showed that a subset of offspring of type 2 diabetic patients had a 100-kDa urinary protein detectable with an anti-nephrin antibody. Offspring who were strongly positive for this protein were more insulinresistant than offspring who were weakly positive or negative for this protein, and insulin resistance was attributable to reduced rates of non-oxidative glucose disposal. These results remained essentially unchanged after the exclusion of subjects with IGT or IFG from statistical analyses. Furthermore, the 100-kDa urinary protein was associated with the rates of WBGU and non-oxidative glucose disposal independently of confounding factors.
In the present study the sizes of the urinary proteins were not identical with those found in type 1 diabetic patients with nephrinuria [16] . We did not find the typical proteins of 75, 40 and 32 kDa that were present in patients with type 1 diabetes. The 100-kDa protein most probably originates from the glomerulus, since glomerular lysate demonstrated a similar-sized band. The protein could be a degradation product of full-sized nephrin, since protease inhibitors do not always work properly on lysates. A protein corresponding to the whole nephrin molecule (185-200 kDa) was also detected in many urine samples, but subjects who were positive or negative for this band did not show any difference in clinical characteristics or laboratory parameters. The origin of the 100-kDa urinary protein remains unknown. Nephrin is expressed in the pancreatic beta cells [11] , but it is unlikely that this protein originates from the pancreas because of the large size of the protein.
We have previously shown that an alternatively spliced nephrin, nephrin α, exists in the human glomerulus at the mRNA level [22] . It is possible that the 100-kDa protein represents this form both in glomeruli and urine. Interestingly, it has been suggested that nephrin is released into urine by podocytes in kidney diseases with proteinuria [23] . It is also possible that the 100-kDa protein has close homology to nephrin and is thus a new or known nephrinlike protein. To identify this protein, it is necessary to precipitate urinary proteins, to separate the desired protein by immunoprecipitation and possibly by two-dimensional gel electrophoresis or by chromatographic methods. The amount of the target protein has to be large enough to allow reliable characterisation with mass-spectrometric methods. Only one study has been published on the massspectrometric identification of nephrin [24] . In that study the authors needed purified nephrin from 100 rat kidneys to be able to identify three nephrin peptides. Further characterisation of our 100-kDa urinary protein is underway.
Nephrin expression is altered in experimental diabetic kidney damage [13, 25] . Glomerular nephrin mRNA was decreased in biopsies of type 2 diabetic patients who had proteinuria, while the results were similar to those in control subjects when the ACE inhibitor perindopril was used [26] . Another study demonstrated a similar reduction in nephrin protein with altered cellular distribution in biopsies of type 1 and type 2 diabetic patients with the nephrotic syndrome [27] . A particularly interesting finding in that study was that angiotensin II caused the excretion of a 100-kDa protein from the glomerular epithelial cells [27] . This protein was detectable with an anti-nephrin antibody, and the excretion phenomenon may have involved cytoskeletal rearrangement. This form of nephrin may be the same as that found in the present study. Our finding that the 100-kDa protein was related to insulin resistance in offspring of type 2 diabetic patients could be due to the activity of the renin angiotensin system, since overactivity of this system may contribute to insulin resistance [28] . Supporting this hypothesis, previous studies have shown that the use of ACE inhibitors and angiotensin II receptor antagonists may prevent diabetes [29] [30] [31] [32] . Thus, we propose that overactivation of the renin angiotensin system may occur in patients positive for the 100-kDa urinary protein, and that this could lead, by unknown mechanisms, to the release of nephrin and its subsequent degradation during passage through the tubular system. Alternatively, insulin resistance itself could lead directly to the overproduction and dominance of soluble spliced nephrin or a nephrin-like protein finally appears in the urine.
Microalbuminuria has been associated with insulin resistance both in diabetic and in non-diabetic subjects in [7, 33, 34] but not in all [35, 36] studies. In the present study only five subjects had a urine sample with albumin excretion value in the microalbuminuric range (30-300 mg/24 h), but none of them showed a strong 100-kDa protein. We did not find any difference between the groups with respect to albumin excretion, and albumin excretion was not associated with M/I or insulin AUC during the first 10 min of the IVGTT. Therefore, insulin resistance in offspring exhibiting the 100-kDa urinary protein was not related to albumin excretion rate, suggesting that insulin resistance may cause early changes in podocyte metabolism. These changes may lead to excretion of the 100-kDa urinary protein without altering slit structure, which causes microalbuminuria. One explanation could be that our study subjects were relatively young and normotensive, and most of them had normal glucose tolerance.
It has been suggested that the number of podocytes is decreased in diabetes [18, 37] . Furthermore, podocytes have been found in urine of micro-and macroalbuminuric type 2 diabetic patients [17] . Since a subset of patients already had microalbuminuria at the time of diagnosis of diabetes, it is possible that they have been losing podocytes for some time. Do the proteins that we found represent these detaching podocytes? When released into urine, proteins from perturbed podocytes may be naturally broken into smaller fractions during their passage through the tubules, particularly the proximal tubule, which is rich in proteolytic activity [38] . Alternatively, possible degradation products could result from exogenous bacterial activity in the voided urine.
In conclusion, we detected proteins visible with antibody against nephrin in the urine of offspring of type 2 diabetic patients. Of these proteins, the 100-kDa protein was associated with impaired insulin sensitivity. Further studies are needed to show if this protein serves as a marker of susceptibility to type 2 diabetes.
